Kidney International · 2019 · 62 citations · 39 references
MedicineImmunologyPathologyInflammationInnate ImmunityRenal PathophysiologyAcute Kidney InjuryCytokine BiologyCytokine-mediated PathologyRenal InflammationRenal IschemiaRenal Ischemic InjuryAcute Kidney Injury PathophysiologyAcute-phase MediatorsBiomarkers Of Renal IschemiaCytokine-mediated Renal InflammationInflammation In Renal InjuryIschemic Acute Kidney InjuryNeutrophil Gelatinase-associated LipocalinRenal Proximal Tubule Injury
Neutrophil gelatinase associated lipocalin (NGAL, Lcn2) is the most widely studied biomarker of acute kidney injury (AKI). Previous studies have demonstrated that NGAL is produced by the kidney and released into the urine and plasma. Consequently, NGAL is currently considered a tubule specific injury marker of AKI. However, the utility of NGAL to predict AKI has been variable suggesting that other mechanisms of production are present. IL-6 is a proinflammatory cytokine increased in plasma by two hours of AKI and mediates distant organ effects. Herein, we investigated the role of IL-6 in renal and extra-renal NGAL production. Wild type mice with ischemic AKI had increased plasma IL-6, increased hepatic NGAL mRNA, increased plasma NGAL, and increased urine NGAL; all reduced in IL-6 knockout mice. Intravenous IL-6 in normal mice increased hepatic NGAL mRNA, plasma NGAL and urine NGAL. In mice with hepatocyte specific NGAL deletion (Lcn2hep-/-) and ischemic AKI, hepatic NGAL mRNA was absent, and plasma and urine NGAL were reduced. Since urine NGAL levels appear to be dependent on plasma levels, the renal handling of circulating NGAL was examined using recombinant human NGAL. After intravenous recombinant human NGAL administration to mice, human NGAL in mouse urine was detected by ELISA during proximal tubular dysfunction, but not in pre-renal azotemia. Thus, during AKI, IL-6 mediates hepatic NGAL production, hepatocytes are the primary source of plasma and urine NGAL, and plasma NGAL appears in the urine during proximal tubule dysfunction. Hence, our data change the paradigm by which NGAL should be interpreted as a biomarker of AKI. Neutrophil gelatinase associated lipocalin (NGAL, Lcn2) is the most widely studied biomarker of acute kidney injury (AKI). Previous studies have demonstrated that NGAL is produced by the kidney and released into the urine and plasma. Consequently, NGAL is currently considered a tubule specific injury marker of AKI. However, the utility of NGAL to predict AKI has been variable suggesting that other mechanisms of production are present. IL-6 is a proinflammatory cytokine increased in plasma by two hours of AKI and mediates distant organ effects. Herein, we investigated the role of IL-6 in renal and extra-renal NGAL production. Wild type mice with ischemic AKI had increased plasma IL-6, increased hepatic NGAL mRNA, increased plasma NGAL, and increased urine NGAL; all reduced in IL-6 knockout mice. Intravenous IL-6 in normal mice increased hepatic NGAL mRNA, plasma NGAL and urine NGAL. In mice with hepatocyte specific NGAL deletion (Lcn2hep-/-) and ischemic AKI, hepatic NGAL mRNA was absent, and plasma and urine NGAL were reduced. Since urine NGAL levels appear to be dependent on plasma levels, the renal handling of circulating NGAL was examined using recombinant human NGAL. After intravenous recombinant human NGAL administration to mice, human NGAL in mouse urine was detected by ELISA during proximal tubular dysfunction, but not in pre-renal azotemia. Thus, during AKI, IL-6 mediates hepatic NGAL production, hepatocytes are the primary source of plasma and urine NGAL, and plasma NGAL appears in the urine during proximal tubule dysfunction. Hence, our data change the paradigm by which NGAL should be interpreted as a biomarker of AKI. Translational StatementAcute kidney injury (AKI) is the most common focus of inpatient consultation with nephrologists, and it is associated with increased morbidity and mortality. Current tools to identify and classify AKI are inadequate. Herein, we extensively characterize the production and renal handling of one of the most widely studied AKI biomarkers—neutrophil gelatinase–associated lipocalin (NGAL)—and demonstrate several new insights into its production and renal handling that may improve its accuracy to identify AKI and distinguish between pre-renal azotemia and acute tubular injury, which have major differences in the approach to clinical care. Given that we demonstrate that the major source of urine NGAL is the plasma and that urine NGAL increases during proximal tubule dysfunction, future studies should incorporate methods to account for plasma NGAL levels in patients with adjudicated pre-renal azotemia and acute tubular injury. Acute kidney injury (AKI) is the most common focus of inpatient consultation with nephrologists, and it is associated with increased morbidity and mortality. Current tools to identify and classify AKI are inadequate. Herein, we extensively characterize the production and renal handling of one of the most widely studied AKI biomarkers—neutrophil gelatinase–associated lipocalin (NGAL)—and demonstrate several new insights into its production and renal handling that may improve its accuracy to identify AKI and distinguish between pre-renal azotemia and acute tubular injury, which have major differences in the approach to clinical care. Given that we demonstrate that the major source of urine NGAL is the plasma and that urine NGAL increases during proximal tubule dysfunction, future studies should incorporate methods to account for plasma NGAL levels in patients with adjudicated pre-renal azotemia and acute tubular injury. Acute kidney injury (AKI) is a common complication in hospitalized patients, occurring in up to 20% of hospital admissions and 30% to 50% of intensive care unit admissions. AKI is an independent risk factor for death, with mortality rates as high as 50% in the intensive care unit.1Palevsky P.M. Zhang J.H. O'Connor T.Z. et al.Intensity of renal support in critically ill patients with acute kidney injury.New Engl J Med. 2008; 359: 7-20Crossref PubMed Scopus (1196) Google Scholar The development of biomarkers that can identify AKI early and more reliably than serum creatinine rise has been a translational research priority for over a decade with the premise that early recognition may lead to improved care and the development of new therapies.2American Society of NephrologyRenal research report.J Am Soc Nephrol. 2005; 16: 1886-1903Crossref PubMed Scopus (158) Google Scholar Neutrophil gelatinase–associated lipocalin (NGAL) (also known as lipocalin 2) is one of the most widely studied AKI biomarkers, having been tested in thousands of patients.3Nickolas T.L. Schmidt-Ott K.M. Canetta P. et al.Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.J Am Coll Cardiol. 2012; 59: 246-255Crossref PubMed Scopus (228) Google Scholar, 4Parikh C.R. Devarajan P. Zappitelli M. et al.Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery.J Am Soc Nephrol. 2011; 22: 1737-1747Crossref PubMed Scopus (256) Google Scholar, 5Kim S. Kim H.J. Ahn H.S. et al.Is plasma neutrophil gelatinase-associated lipocalin a predictive biomarker for acute kidney injury in sepsis patients? A systematic review and meta-analysis.J Crit Care. 2016; 33: 213-223Crossref PubMed Scopus (27) Google Scholar NGAL has been considered an advantageous AKI biomarker6Schmidt-Ott K.M. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury—where do we stand today?.Nephrol Dial Transplant. 2011; 26: 762-764Crossref PubMed Scopus (69) Google Scholar because it is reported to be a kidney-specific marker of AKI that is produced by the kidney during tubular injury.7Paragas N. Qiu A. Zhang Q. et al.The Ngal reporter mouse detects the response of the kidney to injury in real time.Nat Med. 2011; 17: 216-222Crossref PubMed Scopus (297) Google Scholar In addition, it is not influenced by systemic diseases, and it appears in the plasma and urine within 2 hours of injury after being released by injured tubules.8Mishra J. Dent C. Tarabishi R. et al.Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.Lancet. 2005; 365: 1231-1238Abstract Full Text Full Text PDF PubMed Scopus (1794) Google Scholar However, the performance of NGAL in predicting AKI has been variable, possibly because it is produced by cell types outside of the kidney or in response to other stimuli such as systemic inflammation and circulating cytokines.9Xiao X. Yeoh B.S. Vijay-Kumar M. Lipocalin 2: an emerging player in iron homeostasis and inflammation.Annu Rev Nutr. 2017; 37: 103-130Crossref PubMed Scopus (86) Google Scholar Interleukin (IL)-6 is a proinflammatory cytokine that increases within 2 hours in the plasma in patients and mice after AKI10Dennen P. Altmann C. Kaufman J. et al.Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery.Crit Care. 2010; 14: R181Crossref PubMed Scopus (50) Google Scholar,11Klein C.L. Hoke T.S. Fang W.F. et al.Interleukin-6 mediates lung injury ischemic acute kidney injury or 2008; Full Text Full Text PDF PubMed Scopus Google Scholar and a role in NGAL production. In the we investigated the role of IL-6 in NGAL production during AKI. the of IL-6 on plasma and urine NGAL levels during AKI, or mice were to ischemic AKI with renal or with of mice were studied as a for all kidney injury after in or kidney injury was after ischemic AKI in and C.L. Hoke T.S. Fang W.F. et al.Interleukin-6 mediates lung injury ischemic acute kidney injury or 2008; Full Text Full Text PDF PubMed Scopus Google and plasma creatinine were in and with IL-6 was increased in hours after AKI, and and in plasma NGAL was increased in and reduced in and hours after AKI, and urine NGAL was increased and hours after and AKI in and reduced in and in neutrophil gelatinase–associated lipocalin (NGAL) is reduced in mice after ischemic acute kidney injury and and hours IL-6, plasma NGAL, and urine NGAL were in normal mice, and after ischemic AKI, or and hours in and mice. IL-6 was increased in mice, and hours after AKI, and NGAL was reduced in mice and hours after AKI, and NGAL was reduced after and ischemic AKI in to mice are as and by the the and normal the a data demonstrate that IL-6 a role in NGAL production after ischemic AKI, and the of NGAL production after AKI, and NGAL mRNA levels were in the and in and In the NGAL mRNA levels were increased and hours after AKI, and and were reduced and in all in In the NGAL mRNA increased and hours AKI and was not in In the lung and NGAL mRNA was the of NGAL in levels of NGAL were in the and and hours after AKI, and and was examined hours after ischemic AKI. mRNA, NGAL levels were in all the after AKI, and and were reduced in NGAL to the proximal and tubule after AKI The of organ production and of NGAL after ischemic AKI is in neutrophil gelatinase–associated lipocalin (NGAL) production and after ischemic acute kidney injury (AKI) in and mice. NGAL production in and is as a of organ production and that the is the major organ source of NGAL production and hours in mice after ischemic in mice, the kidney is the major source of NGAL production. Thus, IL-6 is a of but not NGAL production. NGAL levels in the and are as a of organ levels and demonstrate that after AKI, NGAL within the and was within organ not distinguish NGAL NGAL within A of NGAL was in mice. of the were to production and between and in mRNA and the that the is the primary of organ production, NGAL is widely the data in to demonstrate that IL-6 to hepatic NGAL production, which in an in plasma NGAL levels in all ischemic AKI, and Since the in plasma IL-6 to an in hepatic NGAL production after ischemic AKI, and we that circulating IL-6 was the to NGAL production in Given that hepatocytes the IL-6 a of IL-6 on hepatocytes is to circulating IL-6 mediates hepatic NGAL production, IL-6 was for hours to mice, and were after the After IL-6 hepatic NGAL production as plasma and urine NGAL NGAL mRNA levels not in the or IL-6 not kidney the plasma IL-6 was increased in the mice, as IL-6 to with AKI increased NGAL mRNA levels and plasma NGAL, but not or NGAL mRNA levels Since the source of IL-6 after is the data demonstrate that circulating IL-6 mediates hepatic NGAL production that to increased plasma NGAL the of hepatic NGAL production, recombinant human IL-6 was to human and NGAL mRNA levels were in and NGAL levels were in the and hours NGAL mRNA levels increased in the by and in the by 2 The of and on NGAL levels in response to IL-6 was in and of IL-6 had a on NGAL levels than In the of renal on plasma IL-6 and NGAL levels was and demonstrated that plasma IL-6 levels plasma and urine NGAL levels hours data demonstrate that NGAL production up to hours after IL-6 IL-6, the and of the factor the role of after ischemic AKI, was in and of the and kidney and hours after AKI in and In the but not the had reduced and to the in the in with the of NGAL production. In IL-6, or IL-6 of was to or human The in NGAL in the after IL-6 was in the IL-6 levels were not a data demonstrate that is for NGAL production in that the is the major source of NGAL production after AKI, ischemic AKI was in and mice are to NGAL in the mice, NGAL production in all other et is the major source of serum levels after or a role for PubMed Scopus Google Scholar hours AKI in plasma and urine NGAL levels were reduced NGAL mRNA was in the and not in the or NGAL levels were in the but not the or kidney and plasma IL-6 levels were to for Given that NGAL is in K.M. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury—where do we stand today?.Nephrol Dial Transplant. 2011; 26: 762-764Crossref PubMed Scopus (69) Google Scholar we tested mice have had plasma and urine NGAL levels to an on by mice to ischemic AKI Neutrophil mice with AKI had a of kidney Neutrophil not plasma NGAL, urine NGAL, or NGAL mRNA levels in the or of NGAL was in the and but reduced in the and lung and lung neutrophil after C.L. Hoke T.S. Fang W.F. et al.Interleukin-6 mediates lung injury ischemic acute kidney injury or 2008; Full Text Full Text PDF PubMed Scopus Google A. R. et IL-6 production in and acute kidney lung 2017; Full Text Full Text PDF PubMed Scopus Google C. N. et lung inflammation in mice with ischemic acute kidney 2017; Full Text Full Text PDF PubMed Scopus Google Scholar the in lung NGAL in the mice a in lung neutrophil and a may be within the Given that our data that urine NGAL is the we the renal handling of circulating NGAL by the of recombinant human NGAL in with of renal or tubular injury in which the was known is to NGAL, and it is by the but to NGAL by and not NGAL levels not were as of pre-renal proximal tubule injury to ischemic and is a that the and R. S. the on by kidney 22: PubMed Scopus Google Scholar and urine were after and urine levels of were in mice with normal kidney and urine were to normal in pre-renal plasma was but in pre-renal urine levels were to In plasma and urine were in injury and ischemic AKI, and plasma levels were increased in mice with In to account for plasma levels and in the of urine of NGAL, we the of as plasma urine was than in normal mice, mice with pre-renal and mice with pre-renal and it was than 20% in mice and mice with ischemic AKI. levels of plasma and urine NGAL, and were with to for data that circulating NGAL is and and by the of the is not a normal of NGAL as urine levels were in mice with normal kidney dysfunction, NGAL is not and and appears in the between pre-renal azotemia and injury in mice with NGAL is the most widely studied AKI having been tested in thousands of patients for its to AKI on early studies that NGAL is produced by the injured kidney and is released into the urine and N. Qiu A. Zhang Q. et al.The Ngal reporter mouse detects the response of the kidney to injury in real time.Nat Med. 2011; 17: 216-222Crossref PubMed Scopus (297) Google Scholar NGAL has been and studied as a tubular injury C.R. of acute kidney serum Nephrol. Full Text Full Text PDF PubMed Scopus Google Scholar In the we examined renal and extra-renal production of NGAL, the of the proinflammatory cytokine IL-6, and the renal handling of NGAL. The major of our are that IL-6 mediates hepatic NGAL production during the the the primary source of plasma and urine NGAL levels during and circulating NGAL appears in the urine during AKI associated with proximal tubular dysfunction. data change the paradigm by which NGAL should be interpreted as a biomarker of AKI and the known role of IL-6 in the systemic response after AKI. studies that have examined NGAL during AKI have on its role as an AKI N. Qiu A. Zhang Q. et al.The Ngal reporter mouse detects the response of the kidney to injury in real time.Nat Med. 2011; 17: 216-222Crossref PubMed Scopus (297) Google J. Q. A. et of neutrophil gelatinase-associated lipocalin as a early urinary biomarker for ischemic renal Am Soc Nephrol. 14: PubMed Scopus Google Scholar and in kidney et of the kidney 2005; PubMed Scopus Google J. Q. et of ischemic acute renal injury by neutrophil gelatinase-associated Am Soc Nephrol. PubMed Scopus Google Scholar of AKI, studies have the systemic of NGAL in a of In it is that NGAL is of the hepatic acute response et is the major source of serum levels after or a role for PubMed Scopus Google Scholar The hepatic is by the hepatic production of that to the to injury, and S. S. 2011; PubMed Scopus Google Scholar NGAL in the hepatic as a the of and in with other iron hepatic such as and iron 2011; PubMed Scopus Google Scholar A. S. et of in IL-6 by ELISA and by of a to PubMed Scopus Google Scholar and M. J. et al.Interleukin-6 hepatic and in PubMed Scopus Google Scholar Given that iron for iron is a The role of NGAL during is by studies that NGAL knockout mice have increased to A. et mice increased to but not to A. PubMed Scopus Google et 2 is for PubMed Scopus Google Scholar IL-6 is a major of the hepatic and hepatocyte production of all et and acute 2005; PubMed Scopus Google Scholar IL-6 production is within by systemic such as and as of the systemic response during AKI. In mice and patients with AKI, the plasma IL-6 increases within 2 T.S. C.L. et renal after is associated with Am Soc Nephrol. PubMed Scopus Google Altmann C. et interleukin-6 and are early biomarkers of acute kidney injury and predict in children undergoing cardiac a Care. PubMed Scopus Google Scholar The production and renal handling of IL-6 during AKI is the kidney is not a major source of IL-6 production, as by the that plasma IL-6 increases after C.L. Hoke T.S. Fang W.F. et al.Interleukin-6 mediates lung injury ischemic acute kidney injury or 2008; Full Text Full Text PDF PubMed Scopus Google T.S. C.L. et renal after is associated with Am Soc Nephrol. PubMed Scopus Google Scholar In the and are the major organ of IL-6 in A. Altmann C. N. et lung injury after ischemic acute kidney injury in J 2011; PubMed Scopus Google Scholar and the major cell source is the C. A. et lung inflammation in a mouse of ischemic acute kidney J 2012; PubMed Scopus Google Scholar of IL-6 is during AKI, as a of proximal tubular and P. Altmann C. Kaufman J. et al.Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery.Crit Care. 2010; 14: R181Crossref PubMed Scopus (50) Google Scholar Given that normal kidney is to plasma IL-6, associated with systemic response and AKI be to with increased levels of plasma IL-6, as has been after Altmann C. et interleukin-6 and are early biomarkers of acute kidney injury and predict in children undergoing cardiac a Care. PubMed Scopus Google et IL-6 and predict AKI and mortality in after cardiac surgery.J Am Soc Nephrol. 26: PubMed Scopus (86) Google Scholar IL-6 is a known of the hepatic and IL-6 levels are increased during AKI, the role of NGAL production during AKI has not been of we demonstrate that circulating IL-6 mediates hepatic NGAL production during AKI. mice with ischemic AKI had reduced plasma NGAL levels that were associated with a in but not mRNA NGAL. NGAL and hepatic NGAL levels were reduced in mice with data in the the that the kidney is not for NGAL production, as plasma NGAL levels were high in mice. are of one other that has examined the role of IL-6 in hepatic NGAL production, in in IL-6 mice were to and and had reduced plasma et is the major source of serum levels after or a role for PubMed Scopus Google Scholar with our IL-6 hepatic NGAL production was by of et is the major source of serum levels after or a role for PubMed Scopus Google Scholar of our is the with which IL-6 can hepatic NGAL production. In our data with administration of IL-6 to normal mice demonstrated that hepatic NGAL production and plasma NGAL were increased within In of IL-6 to hepatocytes increased NGAL levels within 2 and studies have examined and et is the major source of serum levels after or a role for PubMed Scopus Google Scholar The of response is as NGAL production is of the hepatic which after other are during AKI by has not been but our data predict that production of other such as and be during AKI. predict that most associated with systemic response or an in plasma IL-6 be associated with a rise in plasma NGAL of we after in the are of clinical in which plasma IL-6 and NGAL are known to be R. et of serum (IL)-6 in sepsis a systematic review and J Med. Google Scholar, et al.The clinical of a cytokine in the acute of PubMed Scopus Google Scholar, J. M. S. et of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney PubMed Scopus Google Scholar, M. et al.The of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and in early of acute kidney injury in critically ill PubMed Scopus Google Scholar et al.The role of IL-6, and and in the of systemic in patients with acute PubMed Scopus Google M. P. A. et of serum neutrophil gelatinase-associated lipocalin the early of acute 2016; Google Scholar and Altmann C. et interleukin-6 and are early biomarkers of acute kidney injury and predict in children undergoing cardiac a Care. PubMed Scopus Google et IL-6 and predict AKI and mortality in after cardiac surgery.J Am Soc Nephrol. 26: PubMed Scopus (86) Google Scholar The of the of IL-6 on the during AKI with of our studies of systemic of IL-6 during AKI. circulating IL-6 mediates lung inflammation and neutrophil that is hours after the of ischemic N. A. Altmann C. et IL-6 mediates lung injury production after acute kidney injury in J 2012; PubMed Scopus Google R. Altmann C. et IL-6 lung inflammation in but not of acute lung injury in PubMed Scopus Google Scholar IL-6 mediates production in the within which to A. R. et IL-6 production in and acute kidney lung 2017; Full Text Full Text PDF PubMed Scopus Google Scholar data the systemic of IL-6, which may be as a response that the to is to that IL-6 early after AKI, plasma IL-6 levels are by hours to NGAL, our data demonstrate that IL-6 hepatic NGAL production within but it is other to NGAL production, as hepatic NGAL production and plasma levels are increased hours plasma IL-6 levels are In our data demonstrate that is for NGAL production in hepatocytes and that the in of to the may the that NGAL production to hours after IL-6 the of early and during AKI, and the that AKI can change over data in the mice with ischemic AKI demonstrated the role of hepatocyte NGAL production during AKI and the that hepatocyte NGAL production for the of plasma NGAL levels, which in for the of urine NGAL levels Previous studies the source of urine NGAL during AKI demonstrated that NGAL is produced by the kidney and released into the urine and plasma In the of plasma NGAL to urine NGAL levels during AKI was not plasma NGAL during AKI was not and extra-renal production of NGAL mRNA and levels during AKI were not N. Qiu A. Zhang Q. et al.The Ngal reporter mouse detects the response of the kidney to injury in real time.Nat Med. 2011; 17: 216-222Crossref PubMed Scopus (297) Google J. Q. A. et of neutrophil gelatinase-associated lipocalin as a early urinary biomarker for ischemic renal Am Soc Nephrol. 14: PubMed Scopus Google Scholar on of that urine NGAL in AKI is to and of circulating the utility of urine NGAL as a biomarker of AKI, its being produced by the a of our is that a major source of urine NGAL is the a major is that plasma levels of NGAL should be considered urine NGAL levels as a biomarker of AKI. account for plasma NGAL levels, we the of NGAL In clinical is an of the of a that is in the urine and may be to tubular with a to a high of tubular and a high to a of tubular Given that our data demonstrate that circulating NGAL appears in the urine as a of and of circulating NGAL, a to for tubular and is to be in the of urine NGAL in mice with normal with pre-renal was than in all in mice with or ischemic AKI, was than in all after the of was than in as the source of is that which was renal production or be the for high we as that during dysfunction, NGAL may in the but into the urine to a of is in with that NGAL to the et of the kidney 2005; PubMed Scopus Google J. Q. et of ischemic acute renal injury by neutrophil gelatinase-associated Am Soc Nephrol. PubMed Scopus Google Scholar with to be to of NGAL and to within et of the kidney 2005; PubMed Scopus Google Scholar that are to associated with the and of in clinical that urine NGAL is released into the urine during AKI, the the the of tubular injury. In of that a that for plasma NGAL levels and has the to improve the utility of urine NGAL as a biomarker of for pre-renal azotemia acute tubular injury, which is a clinical studies have interpreted urine NGAL as a kidney injury marker a marker of systemic inflammation and dysfunction, we that studies that have NGAL as a marker of AKI may to be is in a of studies that AKI injury a rise in serum on urine NGAL may not have been tubular injury, but of systemic inflammation and increased plasma be associated with sepsis and other of systemic response NGAL levels should be interpreted with in in which inflammation is as by our studies in mice, in which plasma and urine NGAL were reduced a change in kidney our has are a of and it is to that AKI is an systemic and that in the systemic response may on the of AKI and the which are we studied of AKI, the of our studies were with ischemic AKI, and and The of NGAL and its by or other nephron was not of NGAL production and handling may be for other of The renal handling of NGAL during was not is the to identify a specific of NGAL production during AKI, other of hepatic NGAL production IL-6 are as the in plasma NGAL was Thus, IL-6 dependent and independent on the hepatic production of other AKI The major of our are that hepatic NGAL production is the primary source of plasma and urine NGAL during AKI, and that IL-6 is a major of hepatic NGAL production. data the known role of IL-6 in the systemic response after AKI and change the paradigm by which NGAL should be interpreted as a biomarker of AKI. NGAL is a marker of tubular and plasma levels should be for in its the utility of NGAL may be for pre-renal azotemia acute tubular injury.
39
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Manfred Köpf, Heinz Baumann, Giulia Freer et al. · Nature · 1994 · 1.8K citations
Life Sciences, Immunology, Pathology +16